SOLICITATION NOTICE
65 -- Notice of Intent - Opiates Reagent Kit Bridge Contract
- Notice Date
- 5/9/2012
- Notice Type
- Presolicitation
- NAICS
- 325413
— In-Vitro Diagnostic Substance Manufacturing
- Contracting Office
- N62645 Naval Medical Logistics Command 693 Neiman Street Ft. Detrick, MD
- ZIP Code
- 00000
- Solicitation Number
- N6264512R0043
- Response Due
- 5/21/2012
- Archive Date
- 6/21/2012
- Point of Contact
- Nicholas Dankanich 301-619-8419 NMLC Department of Defense(DOD) Drug Testing Program Mailbox at NMLC.DoDDrugTestingProgram@med.navy.mil
- E-Mail Address
-
Opiates Reagent Kit Bridge
(NMLC.DoDDrugTestingProgram@med.navy.mil)
- Small Business Set-Aside
- N/A
- Description
- The Naval Medical Logistics Command intends to issue a two month bridge indefinite delivery indefinite quantity (IDIQ) requirements contract with two, one month option periods on a sole source basis (IAW FAR 6.302-1) with Roche Diagnostics Corporation, 9115 Hague Road, Indianapolis, Indiana 46256. Roche Diagnostics Corporation currently provides the Department of Defense (DOD) Drug Testing Program with opiates reagent kits under a contract N62645-12-D-5015. The current contract expires 31 May 2012. The proposed bridge contract shall have a base period of performance from 01 June 2012 “ 31 July 2012. The bridge contract shall be placed in anticipation of the award of an IDIQ requirements contract resulting from competitive solicitation, N62645-12-R-0007. Roche Diagnostics Corporation shall provide opiate reagent kits for the drug labs located in San Diego, California; Jacksonville, Florida; Great Lakes, Illinois; Lackland Air Force Base, Texas; Fort Meade, Maryland; Tripler Army Medical Center, Hawaii; and Dover Air Force Base, Delaware. This acquisition is being conducted under simplified acquisition procedures (IAW FAR 12 and FAR 16.503). There are no set-aside restrictions for this requirement. The intended procurement will be classified under North American Industry Classification System (NAICS) 325413 with a Small Business Size Standard of 500 employees. This notice of intent is not a request for competitive proposals and no solicitation document exists for this requirement. However, parties interested in responding to this notice will need to submit technical data sufficient to determine capability in providing the same product. All capability statements received within 12 days after publication of this synopsis will be considered by the Government. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Capability statements shall be submitted by email only as a MS Word or Adobe PDF attachment to the NMLC Department of Defense (DOD) Drug Testing Program Mailbox at NMLC.DoDDrugTestingProgram@med.navy.mil (in subject line reference: Opiates Reagent Kits Bridge). Statements are due no later than 21 May 2012, 03:00 PM EST. No phone calls accepted.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/DON/BUMED/N62645/N6264512R0043/listing.html)
- Record
- SN02743193-W 20120511/120509235113-032b5ec379e61edda2a2db6deadc49ff (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |